Zevra Therapeutics (1GDA.F) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.61
0.24
1.09
1.94

Details

Expected EPS
-0.02935845
Actual EPS
-0.0086988
Surprise EPS
0.02
Surprise Percent
+70.37%

Description

Zevra Therapeutics (1GDA.F) has reported earnings of -0.0086988 per share for Q4 2025.

0 Comments

Share your thoughts